Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 2048614)

1.

Outcome of very-low-birth-weight infants exposed to beta-sympathomimetics in utero.

Laros RK Jr, Kitterman JA, Heilbron DC, Cowan RM, Tooley WH.

Am J Obstet Gynecol. 1991 Jun;164(6 Pt 1):1657-64; discussion 1664-5.

PMID:
2048614
2.

Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimetics.

Gemelli M, De Luca F, Manganaro R, Leonardi R, Rando F, Agnetti A, Mami C, Di Pasquale G.

Eur J Pediatr. 1990 Jul;149(10):730-3.

PMID:
1976519
3.

Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.

Weintraub Z, Solovechick M, Reichman B, Rotschild A, Waisman D, Davkin O, Lusky A, Bental Y; Israel Neonatal Network.

Arch Dis Child Fetal Neonatal Ed. 2001 Jul;85(1):F13-7.

4.

Influence of maternal magnesium sulphate and ritodrine treatment on the neonate: a study with six-month follow-up.

Rantonen T, Ekblad U, Grönlund J, Rikalainen H, Välimäki I, Kero P.

Acta Paediatr. 1999 Oct;88(10):1142-6.

PMID:
10565464
5.

Mortality and morbidity in infants with intrauterine growth retardation.

Starfield B, Shapiro S, McCormick M, Bross D.

J Pediatr. 1982 Dec;101(6):978-83.

PMID:
6890576
6.

In utero exposure to terbutaline: effects on infant behavior and maternal self-esteem.

Thayer JS, Hupp SC.

J Obstet Gynecol Neonatal Nurs. 1997 Nov-Dec;26(6):691-700.

PMID:
9395978
7.

Prolonged fetal ritodrine exposure and immediate neonatal outcome.

Musci MN Jr, Abbasi S, Otis C, Bolognese RJ.

J Perinatol. 1988 Winter;8(1):27-32.

PMID:
3236090
8.

Long-term follow up of children exposed in utero to nifedipine or ritodrine for the management of preterm labour.

Houtzager BA, Hogendoorn SM, Papatsonis DN, Samsom JF, van Geijn HP, Bleker OP, van Wassenaer AG.

BJOG. 2006 Mar;113(3):324-31.

PMID:
16487205
10.

A national short-term follow-Up study of extremely low birth weight infants born in Finland in 1996-1997.

Tommiska V, Heinonen K, Ikonen S, Kero P, Pokela ML, Renlund M, Virtanen M, Fellman V.

Pediatrics. 2001 Jan;107(1):E2.

PMID:
11134466
11.

Prenatal ritodrine administration and the incidence of respiratory distress syndrome in premature infants.

Kerem E, Dollberg S, Paz I, Armon Y, Seidman DS, Stevenson DK, Gale R.

J Perinatol. 1997 Mar-Apr;17(2):101-6.

PMID:
9134506
12.

Neonatal complications following in utero exposure to intravenous ritodrine.

Kazzi NJ, Gross TL, Kazzi GM, Williams TG.

Acta Obstet Gynecol Scand. 1987;66(1):65-9.

PMID:
3604595
13.
14.

Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.

Van De Water M, Kessel ET, De Kleine MJ, Oei SG.

Acta Obstet Gynecol Scand. 2008;87(3):340-5. doi: 10.1080/00016340801913189.

PMID:
18307075
15.

Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.

Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F.

Pediatrics. 2006 Jun;117(6):e1213-22. Epub 2006 May 22.

PMID:
16717120
16.

Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.

Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA.

J Perinatol. 2005 May;25(5):336-40.

PMID:
15861198
17.
20.

The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.

Riaz M, Porat R, Brodsky NL, Hurt H.

J Perinatol. 1998 Nov-Dec;18(6 Pt 1):449-54.

PMID:
9848759
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk